Davis Polk advised the underwriters in the offering while Jones Day advised GenScript Biotech Corporation.Legend Biotech Corporation executed its $403 million SEC-registered follow-on offering of 9,361,000 American…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
